The Research Antibodies and Reagents Market is expected to grow at a CAGR of 5.6% from 2020 to 2027 to reach USD 6.32 billion by 2027. Due to high specificity, binding affinity, long half-lives, and low toxicity, antibodies are considered as an effective tool for research, diagnostic, and therapeutic purposes. Antibodies are invaluable reagents for antigen detection and purification, which includes immunoblotting, immunoprecipitation, immunohistochemistry, and more. The growth in the global research antibodies market is majorly driven by factors such as rising proteomics & genomic research studies, increase in the funding for research activities, and growing industry-academia collaborations. Further, rising demand for protein therapeutics and personalized medicine, rising investment and focus in the area of stem cell research, rising need for new biomarker identification, and growing research investments in emerging Asia-Pacific and Latin American markets offer significant growth opportunities for players operating in the research antibodies and reagents market.
Here are the top 10 companies operating in the Research Antibodies and Reagents Market
Founded in 1998 and headquartered at Cambridge, U.K.; Abcam plc is engaged in producing and marketing high quality research antibodies and protein research tools for life science researchers. The company offers products such as antibodies, research antibodies, in-vitro diagnostic antibodies, and custom products with a count of approximately 112,000 products for various diseases such as cancer and immune deficiency disorders.
With its subsidiaries and strong network of distribution, the company has its presence in the Americas, Europe, China, Japan, and other Asia-Pacific countries.
Merck KGaA (Germany)
Founded in 1668 and headquartered at Darmstadt, Germany; Merck KGaA is engaged in delivering innovative health solutions in the form of prescription medicines, biologic therapies, and animal healthcare products. The company operates through three business segments as healthcare, life science, and performance materials. It provides research antibody related products through its subsidiary, Merck Millipore, under its Life Sciences business segment.
With many subsidiaries and strong network of distribution, the company has its presence in the North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Founded in 1999 and located at Danvers, MA, U.S; Cell Signaling Technology, Inc. is engaged in providing research and diagnostic products for accelerating biological understanding and enabling personalized medicine under the trademarks such as CellSimple, CST, Cell Signaling Technology, and others. In addition to this, the company is also actively involved in the development of new technologies for signalling analysis as well as mechanistic cell biology research.
With its strong network of distributors, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regional offices are present in the U.S., China, Netherlands, Japan, Austria, Belgium, and Germany.
GE Healthcare (U.S.)
Incorporated in 1892 and headquartered at Illinois, the U.S.; GE Healthcare, a subsidiary of General Electric (GE), offers medical imaging, diagnostics, therapeutics, biopharmaceutical manufacturing, patient monitoring, and drug discovery products. The company operates through two business segments, namely, Healthcare Systems and Life Sciences. The company provides research antibodies and reagents under the Life Sciences business segment.
With its strong distribution network, the company serves in more than 140 countries in U.S., Europe, Asia, Americas, and Middle-East & Africa.
Founded in 2006 and headquartered at Massachusetts, U.S.; Thermo Fisher Scientific Inc., is engaged in providing analytical instruments, equipment, reagents & consumables, and software & services for research, manufacturing, analysis, discovery, and diagnostics under premier brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services. The company operates through four business segments namely Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Services. The company provides research antibodies and reagents under the Life Sciences Solution business segment.
The company has strong presence in the U.S. and China, and offers its products and services through a direct sales force, customer-service professionals, e-commerce platforms, and third-party distributors in other geographies.
Meticulous Research in its latest publication on Research Antibodies and Reagents Market has predicted the growth of 5.6% during the forecast year 2020 to 2027
F. Hoffmann-La Roche AG (Germany)
Founded in 1896 and headquartered at Basel, Switzerland; F. Hoffmann-La Roche AG is a pioneer in healthcare industry. The company operates through two major business segments namely, pharmaceuticals and diagnostics which are focused on advancing science to improve people’s lives. The diagnostic division namely, Roche Diagnostics manufactures equipment and reagents for research and medical diagnostic applications. The Diagnostics Division consists of the following four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics, and Tissue Diagnostics. The company provides research antibodies and reagents under Roche Pharmaceuticals business segment.
The company has its presence across Switzerland, Germany, United States, Latin America, Japan, Africa, Australia, and Oceania.
Founded in 1991 and headquartered at Dellas, Texas, U.S.; Santa Cruz Biotechnology, Inc. is engaged in developing products for the biomedical research market in the areas such as research monoclonal antibodies, labware, biochemicals, and CRISPR products, under the brands CrystalCruz, EZ Touch, ChemCruz, and others.
Through distributors, the company has its presence across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regional offices are present in the U.S., Germany and China.
Becton Dickinson and Company (U.S.)
Founded in 1897 and headquartered at New Jersey, U.S.; Becton Dickinson and Company offers several medical technologies aimed at improving medical discovery, diagnostics, and delivery of care. The company operates in two business segments – BD Medical and BD Life sciences. The company provides research antibodies under BD life sciences business segment through its subsidiary PharMingen.
With its subsidiaries and strong network of distributors, the company has its presence in more than 50 countries across North America, Europe, Asia-Pacific, Latin America and, Middle East & Africa.
Founded in 1962 and headquartered at Pennsylvania, U.S.; Rockland Immunochemicals Inc. is engaged in developing research antibody products validated by the most demanding assays along with the adherence to QSR/cGMP quality standards for ensuring accuracy and repeatability. The company is involved in antibody production, antibody purification, and antibody conjugation along with its customization as per requirements.
Through its strong network of distribution, the company has its presence in the U.S., Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Hong Kong, India, Israel, Italy, Japan, Malaysia, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Singapore, Spain, South Africa, South Korea, Sweden, Switzerland, Taiwan, Tunisia, and the U.K.
Johnson and Johnson (U.S.)
Founded in 1887 and headquartered at New Jersey, U.S.; Johnson and Johnson is engaged in research and development, manufacture, and sales of wide range of products in healthcare field. The company operates through three business segments – Consumer, Pharmaceuticals, and Medical Devices and diagnostics. The company provides pharmaceuticals related products through its subsidiary, Genmab A/S, part of Janssen Pharmaceutica NV. The company provides research antibodies and reagents under Pharmaceuticals business segment.
With its many subsidiaries and strong network of distribution, the company has its presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Authoritative Research on the Research Antibodies and Reagents Market – Global Opportunity Analysis and Industry Forecast (2020-2027)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.